Efficacy of TMS for Depression compared with other treatments

For several years now, neuromodulation treatments such as TMS have emerged as a promising therapeutic options for people suffering from depression who do not respond to traditional therapies such as medication and psychotherapy. Here is a brief review of the most recent studies on the effectiveness of TMS as monotherapy and as combined therapy.

How effective is TMS compared to other treatments for depression?

Studies and meta-analyses have consistently shown that TMS is an effective treatment for depression. A review of different antidepressant treatments found that TMS had comparable response and remission rates to psychotherapy and medication, but with a unique focus on treatment-resistant depression (TRD). Furthermore, studies show that TMS is effective as monotherapy, with response and remission rates of up to 50%).

One of the benefits of TMS is its targeted approach to depression. By using magnetic fields to stimulate specific regions of the brain, TMS can activate neural pathways that have been disrupted in depression. This targeted approach makes TMS an attractive treatment option for individuals who have not responded to other treatments.

Moreover, TMS is a relatively safe treatment option. With correct screening procedures there are no serious side effects, other than a mild focal headache. TMS also does not carry the risk of dependence or withdrawal symptoms associated with some antidepressant medications.

Combining TMS with Psychotherapy enhances depression therapy

A recent study conducted by Donse and colleagues (2018) compared the effectiveness of TMS monotherapy to TMS combined with psychotherapy. The study found that a combination of TMS and psychotherapy led to significant clinical improvements, including a 55% remission rate. This is in contrast to similar studies using TMS as monotherapy, which showed remission rates of 31-37%². This suggests that combining TMS with psychotherapy may lead to even better treatment outcomes.

It is important to note that TMS is not a standalone treatment for depression. Rather, it is best used in conjunction with other treatments, such as psychotherapy. A combination of TMS and psychotherapy, sometimes referred to as “talk and pills,” may be particularly effective for individuals with TRD who have not responded to other treatments.

In conclusion, TMS is a promising treatment option for depression, especially for individuals who have not responded to traditional treatments. Studies and meta-analyses have consistently shown that TMS is effective as monotherapy, with response and remission rates comparable to other treatments like medication and psychotherapy. Furthermore, combining TMS with psychotherapy may lead to even better treatment outcomes. While more research is needed to fully understand the effectiveness of TMS in treating depression, the current evidence suggests that it is a valuable treatment option for individuals with TRD.

Written by neurocare.

neurocare is a global network of clinics changing the way mental health is treated. neurocare recognise that people have distinct needs and goals, as well as unique brain physiology and patterns of thinking. neurocare clinicians provide individualised support for each client’s circumstances based on personalised assessment.

About HealthShare

HealthShare is a leading digital health company. We are dedicating to improving health outcomes for patients through our innovative products for GPs, Specialists, Health organisations and more. To see how we can help you, visit our main website.